BioSupply Trends Quarterly logo
Subscribe
Winter 2026 - Critical Care
  Download Issue
Share

Up Front

Publisher's Corner
New Therapies Show Promise for Treating Critical Illnesses
By Patrick M. Schmidt

Features

Using Synthetic Biology to Create Therapeutic Solutions

BioSupply Trends Quarterly Winter 2026 Human Plasma How it's Being Used to Fight Cancer

Plasma’s Pivotal Role in Cancer Therapy

Myths & Facts: Heart Disease (2026)

Complement Inhibitors as Therapeutic Agents for Autoimmune Disease

Virtual Hospitals: A New Era of Care

BioTrends Watch

Washington Report
HHS Doubles AI-Backed Cancer Research Funding
NIH Launches $50 Million Autism Data Science Initiative
$3.4 Million Grant Awarded to Study Treatments for CCHFV
NIH Grant Awarded to Study Treatment for Crohn's Disease
Reimbursement FAQs
Payment in 2026 Necessitates Being Proactive
Healthcare Management
Revisiting HIPAA: Updates to Know
Industry News
Study Shows Hormone Therapy Is Linked to Autoimmune Disease
FDA Accepts NDA for Leniolisib to Treat Children with APDS
COVID mRNA Vaccine Induces Immune Response Against Cancer
FDA Approves Libtayo for Cutaneous Squamous Call Carcinoma
Study Finds Possible Link Between Chronic Pain and Eosinophilia
Study Shows ALS May Be an Autoimmune Disorder
Merck’s Pneumococcal Vaccine Elicits Immune Responses to 21 Serotypes in Children with one or More Health Conditions
FDA Expands Approval for Recombinant VWF

BioFocus

Industry Insight
SARS-CoV-2 and COVID-19: Plasma Supply and IG Replacement Therapy to Protect Immunodeficient Patients
By Terry O. Harville, MD, PhD
Patient Profile
Heart Disease: A Patient's Perspective — Heather Bardeleben
By Trudie Mitschang
Physician Profile
Heart Disease: A Physician's Perspective — Nancy Sweitzer
By Trudie Mitschang

BioSources